1. Bagheri, Hadi, Mosallaei, Meysam, Bagherpour, Bahram, Salehi, Ahmad Reza, Salehi, Rasoul. 2020. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis. In The journal of gene medicine, 22, e3189. doi:10.1002/jgm.3189. https://pubmed.ncbi.nlm.nih.gov/32196834/
2. Fullár, Alexandra, Karászi, Katalin, Hollósi, Péter, Dudás, József, Kovalszky, Ilona. 2020. Two ways of epigenetic silencing of TFPI2 in cervical cancer. In PloS one, 15, e0234873. doi:10.1371/journal.pone.0234873. https://pubmed.ncbi.nlm.nih.gov/32559232/
3. Gu, Tiezheng, Vasilatos, Shauna N, Yin, Jun, Davidson, Nancy E, Huang, Yi. 2024. Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer. In Cancer letters, 600, 217182. doi:10.1016/j.canlet.2024.217182. https://pubmed.ncbi.nlm.nih.gov/39154703/
4. Guan, Guoying, Xie, Jinjiao, Dai, Yamei, Han, Hui. 2022. TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy. In The Journal of biological chemistry, 298, 101725. doi:10.1016/j.jbc.2022.101725. https://pubmed.ncbi.nlm.nih.gov/35157852/
5. Xia, Zongyi, Zhou, Chi, Hong, Yefeng, Lian, Zhenxun, Guo, Mengqi. 2024. TFPI2 hypermethylation promotes diabetic atherosclerosis progression through the Ap2α/PPARγ axis. In Journal of molecular and cellular cardiology, 198, 45-59. doi:10.1016/j.yjmcc.2024.11.010. https://pubmed.ncbi.nlm.nih.gov/39631358/
6. Hibi, Kenji, Goto, Tetsuhiro, Kitamura, Yo-Hei, Nemoto, Hiroshi, Sanada, Yutaka. . Methylation of the TFPI2 gene is frequently detected in advanced gastric carcinoma. In Anticancer research, 30, 4131-3. doi:. https://pubmed.ncbi.nlm.nih.gov/21036731/
智鼠故事 
